MINIPRESS XL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Minipress Xl, and when can generic versions of Minipress Xl launch?
Minipress Xl is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MINIPRESS XL is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minipress Xl
A generic version of MINIPRESS XL was approved as prazosin hydrochloride by TEVA PHARMS on September 12th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MINIPRESS XL?
- What are the global sales for MINIPRESS XL?
- What is Average Wholesale Price for MINIPRESS XL?
Summary for MINIPRESS XL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 27 |
Patent Applications: | 1,782 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MINIPRESS XL at DailyMed |
Recent Clinical Trials for MINIPRESS XL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1/Phase 2 |
University of Washington | Phase 4 |
Fast Grants | Phase 2 |
US Patents and Regulatory Information for MINIPRESS XL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-001 | Jan 29, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-002 | Jan 29, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MINIPRESS XL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-002 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-001 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-001 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MINIPRESS XL
See the table below for patents covering MINIPRESS XL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 15606 | ⤷ Sign Up | |
Australia | 2244377 | ⤷ Sign Up | |
Malaysia | 8100271 | NOVEL CRYSTALLINE FORMS OF PRAZOSIN HYDROCHLORIDE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |